Emerging data indicates that retatrutide, a innovative medication, could represent a significant advance in weight reduction . This treatment combines the properties of a GLP-1 agonist and a GIP receptor , seemingly offering a more benefit than existing solutions. Patient research have shown promising findings , including substantial decreases in